Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.
The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.
The findings of a recent study indicate that antibodies to gut microbes could help identify who may benefit from teplizumab.
The findings of a recent study suggest that the conversion of dietary fiber or lactate to SCFAs influences comorbidity risk associated with HIV.
The findings of a recent study suggest that fecal microbiota transplants reduce colonization with multidrug-resistant organisms in people who received kidney transplants.
The findings of a recent study suggest that antibiotics should be prescribed with caution in cancer patients who are planning to receive PD-1 inhibitors.
By suggesting that the bacteria detected in the brain after severe pneumonia originate from the lungs, the findings shed light onto the mechanisms of pneumonia-induced neurological conditions.
The findings of a recent study may inform new therapies to modulate the skin microbiota in people with leishmaniasis.
The findings of a recent study link the gut microbiota and the microorganisms responsible for bloodstream infection in critically ill patients.
The findings of a recent study suggest that, during SARS-CoV-2 infection, some bacteria in the upper airways’ microbiota may be associated with a person’s disease progression to intubation.
